|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 10 mg ZD4054 in Combination with Docetaxel in comparison with Docetaxel in Patients with Metastatic Hormone-resistant Prostate Cancer
|
|
|
Disease Condition |
Metastatic Hormone-resistant Prostate Cancer
|
|
|
Phase of Trial |
Phase-3
|
Discipline |
Oncology
|
|
|
Start date of Trial |
10/1/2007
|
Closing Date of Trial |
10/1/2011
|
|
|
|